Near-infrared  ||| S:0 E:14 ||| JJ
spectroscopy  ||| S:14 E:27 ||| JJ
technique  ||| S:27 E:37 ||| NN
to  ||| S:37 E:40 ||| TO
evaluate  ||| S:40 E:49 ||| VB
the  ||| S:49 E:53 ||| DT
effects  ||| S:53 E:61 ||| NNS
of  ||| S:61 E:64 ||| IN
red  ||| S:64 E:68 ||| JJ
blood  ||| S:68 E:74 ||| NN
cell  ||| S:74 E:79 ||| NN
transfusion  ||| S:79 E:91 ||| NN
on  ||| S:91 E:94 ||| IN
tissue  ||| S:94 E:101 ||| NN
oxygenation  ||| S:101 E:113 ||| VBD
The  ||| S:113 E:117 ||| DT
aim  ||| S:117 E:121 ||| NN
of  ||| S:121 E:124 ||| IN
this  ||| S:124 E:129 ||| DT
study  ||| S:129 E:135 ||| NN
was  ||| S:135 E:139 ||| VBD
to  ||| S:139 E:142 ||| TO
evaluate  ||| S:142 E:151 ||| VB
the  ||| S:151 E:155 ||| DT
effects  ||| S:155 E:163 ||| NNS
of  ||| S:163 E:166 ||| IN
red  ||| S:166 E:170 ||| JJ
blood  ||| S:170 E:176 ||| NN
cell  ||| S:176 E:181 ||| NN
( ||| S:181 E:182 ||| -LRB-
RBC ||| S:182 E:185 ||| NNP
)  ||| S:185 E:187 ||| -RRB-
transfusions  ||| S:187 E:200 ||| NN
on  ||| S:200 E:203 ||| IN
muscle  ||| S:203 E:210 ||| NN
tissue  ||| S:210 E:217 ||| NN
oxygenation ||| S:217 E:228 ||| NN
,  ||| S:228 E:230 ||| ,
oxygen  ||| S:230 E:237 ||| JJ
metabolism  ||| S:237 E:248 ||| NN
and  ||| S:248 E:252 ||| CC
microvascular  ||| S:252 E:266 ||| JJ
reactivity  ||| S:266 E:277 ||| NN
in  ||| S:277 E:280 ||| IN
critically  ||| S:280 E:291 ||| RB
ill  ||| S:291 E:295 ||| JJ
patients  ||| S:295 E:304 ||| NNS
using  ||| S:304 E:310 ||| VBG
near-infrared  ||| S:310 E:324 ||| JJ
spectroscopy  ||| S:324 E:337 ||| NNS
( ||| S:337 E:338 ||| -LRB-
NIRS ||| S:338 E:342 ||| NNP
)  ||| S:342 E:344 ||| -RRB-
technology ||| S:344 E:354 ||| NN
.  ||| S:354 E:356 ||| .
This  ||| S:356 E:361 ||| DT
prospective ||| S:361 E:372 ||| JJ
,  ||| S:372 E:374 ||| ,
observational  ||| S:374 E:388 ||| JJ
study  ||| S:388 E:394 ||| NN
included  ||| S:394 E:403 ||| VBD
44  ||| S:403 E:406 ||| CD
consecutive  ||| S:406 E:418 ||| JJ
patients  ||| S:418 E:427 ||| NNS
hospitalized  ||| S:427 E:440 ||| VBN
in  ||| S:440 E:443 ||| IN
the  ||| S:443 E:447 ||| DT
31-bed ||| S:447 E:453 ||| NNP
,  ||| S:453 E:455 ||| ,
medical-surgical  ||| S:455 E:472 ||| JJ
intensive  ||| S:472 E:482 ||| JJ
care  ||| S:482 E:487 ||| NN
unit  ||| S:487 E:492 ||| NN
of  ||| S:492 E:495 ||| IN
a  ||| S:495 E:497 ||| DT
university  ||| S:497 E:508 ||| NN
hospital  ||| S:508 E:517 ||| NN
with  ||| S:517 E:522 ||| IN
anemia  ||| S:522 E:529 ||| NNS
requiring  ||| S:529 E:539 ||| VBG
red  ||| S:539 E:543 ||| JJ
blood  ||| S:543 E:549 ||| NN
cell  ||| S:549 E:554 ||| NN
transfusion ||| S:554 E:565 ||| NN
.  ||| S:565 E:567 ||| .
Thenar  ||| S:567 E:574 ||| FW
tissue  ||| S:574 E:581 ||| FW
oxygen  ||| S:581 E:588 ||| FW
saturation  ||| S:588 E:599 ||| FW
( ||| S:599 E:600 ||| -LRB-
StO2 ||| S:600 E:604 ||| NNP
)  ||| S:604 E:606 ||| -RRB-
and  ||| S:606 E:610 ||| CC
muscle  ||| S:610 E:617 ||| NN
tissue  ||| S:617 E:624 ||| NN
hemoglobin  ||| S:624 E:635 ||| NN
index  ||| S:635 E:641 ||| NN
( ||| S:641 E:642 ||| -LRB-
THI ||| S:642 E:645 ||| NNP
)  ||| S:645 E:647 ||| -RRB-
were  ||| S:647 E:652 ||| VBD
measured  ||| S:652 E:661 ||| VBN
using  ||| S:661 E:667 ||| VBG
a  ||| S:667 E:669 ||| DT
tissue  ||| S:669 E:676 ||| NN
spectrometer  ||| S:676 E:689 ||| NNS
( ||| S:689 E:690 ||| -LRB-
InSpectra  ||| S:690 E:700 ||| NNP
Model  ||| S:700 E:706 ||| NNP
325 ||| S:706 E:709 ||| CD
;  ||| S:709 E:711 ||| :
Hutchinson  ||| S:711 E:722 ||| NNP
Technology  ||| S:722 E:733 ||| NNP
Inc. ||| S:733 E:737 ||| NNP
,  ||| S:737 E:739 ||| ,
Hutchinson ||| S:739 E:749 ||| NNP
,  ||| S:749 E:751 ||| ,
MN ||| S:751 E:753 ||| NNP
,  ||| S:753 E:755 ||| ,
USA ||| S:755 E:758 ||| NNP
) ||| S:758 E:759 ||| -RRB-
.  ||| S:759 E:761 ||| .
A  ||| S:761 E:763 ||| DT
vaso-occlusive  ||| S:763 E:778 ||| JJ
test  ||| S:778 E:783 ||| NN
was  ||| S:783 E:787 ||| VBD
performed  ||| S:787 E:797 ||| VBN
before  ||| S:797 E:804 ||| IN
and  ||| S:804 E:808 ||| CC
1  ||| S:808 E:810 ||| CD
hour  ||| S:810 E:815 ||| NN
after  ||| S:815 E:821 ||| IN
RBC  ||| S:821 E:825 ||| NNP
transfusion  ||| S:825 E:837 ||| NN
by  ||| S:837 E:840 ||| IN
rapid  ||| S:840 E:846 ||| JJ
inflation  ||| S:846 E:856 ||| NN
of  ||| S:856 E:859 ||| IN
a  ||| S:859 E:861 ||| DT
pneumatic  ||| S:861 E:871 ||| JJ
cuff  ||| S:871 E:876 ||| NN
around  ||| S:876 E:883 ||| IN
the  ||| S:883 E:887 ||| DT
upper  ||| S:887 E:893 ||| JJ
arm ||| S:893 E:896 ||| NN
.  ||| S:896 E:898 ||| .
The  ||| S:898 E:902 ||| DT
following  ||| S:902 E:912 ||| JJ
variables  ||| S:912 E:922 ||| NNS
were  ||| S:922 E:927 ||| VBD
recorded ||| S:927 E:935 ||| VBN
:  ||| S:935 E:937 ||| :
THI ||| S:937 E:940 ||| NNP
,  ||| S:940 E:942 ||| ,
the  ||| S:942 E:946 ||| DT
StO2  ||| S:946 E:951 ||| JJ
desaturation  ||| S:951 E:964 ||| JJ
slope  ||| S:964 E:970 ||| NN
during  ||| S:970 E:977 ||| IN
the  ||| S:977 E:981 ||| DT
occlusion  ||| S:981 E:991 ||| NN
( ||| S:991 E:992 ||| -LRB-
% ||| S:992 E:993 ||| NN
/ ||| S:993 E:994 ||| CD
minute ||| S:994 E:1000 ||| NN
)  ||| S:1000 E:1002 ||| -RRB-
and  ||| S:1002 E:1006 ||| CC
the  ||| S:1006 E:1010 ||| DT
StO2  ||| S:1010 E:1015 ||| JJ
upslope  ||| S:1015 E:1023 ||| NN
of  ||| S:1023 E:1026 ||| IN
the  ||| S:1026 E:1030 ||| DT
reperfusion  ||| S:1030 E:1042 ||| JJ
phase  ||| S:1042 E:1048 ||| NN
following  ||| S:1048 E:1058 ||| VBG
the  ||| S:1058 E:1062 ||| DT
ischemic  ||| S:1062 E:1071 ||| JJ
period  ||| S:1071 E:1078 ||| NN
( ||| S:1078 E:1079 ||| -LRB-
% ||| S:1079 E:1080 ||| NN
/ ||| S:1080 E:1081 ||| :
second ||| S:1081 E:1087 ||| LS
) ||| S:1087 E:1088 ||| -RRB-
.  ||| S:1088 E:1090 ||| .
Muscle  ||| S:1090 E:1097 ||| NN
oxygen  ||| S:1097 E:1104 ||| NN
consumption  ||| S:1104 E:1116 ||| NN
( ||| S:1116 E:1117 ||| -LRB-
NIR  ||| S:1117 E:1121 ||| NNP
VO2 ||| S:1121 E:1124 ||| NNP
;  ||| S:1124 E:1126 ||| :
arbitrary  ||| S:1126 E:1136 ||| JJ
units ||| S:1136 E:1141 ||| NNS
)  ||| S:1141 E:1143 ||| -RRB-
was  ||| S:1143 E:1147 ||| VBD
calculated  ||| S:1147 E:1158 ||| VBN
as  ||| S:1158 E:1161 ||| IN
the  ||| S:1161 E:1165 ||| DT
product  ||| S:1165 E:1173 ||| NN
of  ||| S:1173 E:1176 ||| IN
the  ||| S:1176 E:1180 ||| DT
inverse  ||| S:1180 E:1188 ||| JJ
StO2  ||| S:1188 E:1193 ||| CD
desaturation  ||| S:1193 E:1206 ||| JJ
slope  ||| S:1206 E:1212 ||| NN
and  ||| S:1212 E:1216 ||| CC
the  ||| S:1216 E:1220 ||| DT
mean  ||| S:1220 E:1225 ||| JJ
THI  ||| S:1225 E:1229 ||| NN
over  ||| S:1229 E:1234 ||| IN
the  ||| S:1234 E:1238 ||| DT
first  ||| S:1238 E:1244 ||| JJ
minute  ||| S:1244 E:1251 ||| NN
of  ||| S:1251 E:1254 ||| IN
arterial  ||| S:1254 E:1263 ||| JJ
occlusion ||| S:1263 E:1272 ||| NN
.  ||| S:1272 E:1274 ||| .
Blood  ||| S:1274 E:1280 ||| NN
transfusion  ||| S:1280 E:1292 ||| NN
resulted  ||| S:1292 E:1301 ||| VBD
in  ||| S:1301 E:1304 ||| IN
increases  ||| S:1304 E:1314 ||| NNS
in  ||| S:1314 E:1317 ||| IN
hemoglobin  ||| S:1317 E:1328 ||| NN
( ||| S:1328 E:1329 ||| -LRB-
from  ||| S:1329 E:1334 ||| IN
7.1  ||| S:1334 E:1338 ||| CD
( ||| S:1338 E:1339 ||| -LRB-
6.7  ||| S:1339 E:1343 ||| CD
to  ||| S:1343 E:1346 ||| TO
7.7 ||| S:1346 E:1349 ||| CD
)  ||| S:1349 E:1351 ||| -RRB-
to  ||| S:1351 E:1354 ||| TO
8.4  ||| S:1354 E:1358 ||| CD
( ||| S:1358 E:1359 ||| -LRB-
7.1  ||| S:1359 E:1363 ||| CD
to  ||| S:1363 E:1366 ||| TO
9 ||| S:1366 E:1367 ||| CD
)  ||| S:1367 E:1369 ||| -RRB-
g ||| S:1369 E:1370 ||| FW
/ ||| S:1370 E:1371 ||| FW
dl ||| S:1371 E:1373 ||| FW
;  ||| S:1373 E:1375 ||| :
P  ||| S:1375 E:1377 ||| NN
< ||| S:1377 E:1379 ||| SYM
0.01 ||| S:1379 E:1383 ||| CD
)  ||| S:1383 E:1385 ||| -RRB-
and  ||| S:1385 E:1389 ||| CC
in  ||| S:1389 E:1392 ||| IN
oxygen  ||| S:1392 E:1399 ||| JJ
delivery  ||| S:1399 E:1408 ||| NN
( ||| S:1408 E:1409 ||| -LRB-
from  ||| S:1409 E:1414 ||| IN
306  ||| S:1414 E:1418 ||| CD
( ||| S:1418 E:1419 ||| -LRB-
259  ||| S:1419 E:1423 ||| CD
to  ||| S:1423 E:1426 ||| TO
337 ||| S:1426 E:1429 ||| CD
)  ||| S:1429 E:1431 ||| -RRB-
to  ||| S:1431 E:1434 ||| TO
356  ||| S:1434 E:1438 ||| CD
( ||| S:1438 E:1439 ||| -LRB-
332  ||| S:1439 E:1443 ||| CD
to  ||| S:1443 E:1446 ||| TO
422 ||| S:1446 E:1449 ||| CD
)  ||| S:1449 E:1451 ||| -RRB-
ml ||| S:1451 E:1453 ||| FW
/ ||| S:1453 E:1454 ||| FW
minute ||| S:1454 E:1460 ||| FW
/ ||| S:1460 E:1461 ||| FW
m2 ||| S:1461 E:1463 ||| FW
;  ||| S:1463 E:1465 ||| :
P  ||| S:1465 E:1467 ||| NNP
< ||| S:1467 E:1469 ||| SYM
0.001 ||| S:1469 E:1474 ||| NNP
) ||| S:1474 E:1475 ||| -RRB-
.  ||| S:1475 E:1477 ||| .
However ||| S:1477 E:1484 ||| RB
,  ||| S:1484 E:1486 ||| ,
systemic  ||| S:1486 E:1495 ||| JJ
VO2  ||| S:1495 E:1499 ||| NN
was  ||| S:1499 E:1503 ||| VBD
unchanged ||| S:1503 E:1512 ||| JJ
.  ||| S:1512 E:1514 ||| .
RBC  ||| S:1514 E:1518 ||| NNP
transfusion  ||| S:1518 E:1530 ||| NN
did  ||| S:1530 E:1534 ||| VBD
not  ||| S:1534 E:1538 ||| RB
globally  ||| S:1538 E:1547 ||| RB
affect  ||| S:1547 E:1554 ||| VB
NIRS-derived  ||| S:1554 E:1567 ||| JJ
variables ||| S:1567 E:1576 ||| NNS
,  ||| S:1576 E:1578 ||| ,
but  ||| S:1578 E:1582 ||| CC
there  ||| S:1582 E:1588 ||| EX
was  ||| S:1588 E:1592 ||| VBD
considerable  ||| S:1592 E:1605 ||| JJ
interindividual  ||| S:1605 E:1621 ||| JJ
variation ||| S:1621 E:1630 ||| NN
.  ||| S:1630 E:1632 ||| .
Changes  ||| S:1632 E:1640 ||| NNS
in  ||| S:1640 E:1643 ||| IN
the  ||| S:1643 E:1647 ||| DT
StO2  ||| S:1647 E:1652 ||| JJ
upslope  ||| S:1652 E:1660 ||| NN
of  ||| S:1660 E:1663 ||| IN
the  ||| S:1663 E:1667 ||| DT
reperfusion  ||| S:1667 E:1679 ||| JJ
phase  ||| S:1679 E:1685 ||| NN
after  ||| S:1685 E:1691 ||| IN
transfusion  ||| S:1691 E:1703 ||| NN
were  ||| S:1703 E:1708 ||| VBD
negatively  ||| S:1708 E:1719 ||| RB
correlated  ||| S:1719 E:1730 ||| VBN
with  ||| S:1730 E:1735 ||| IN
baseline  ||| S:1735 E:1744 ||| CD
StO2  ||| S:1744 E:1749 ||| CD
upslope  ||| S:1749 E:1757 ||| NN
of  ||| S:1757 E:1760 ||| IN
the  ||| S:1760 E:1764 ||| DT
reperfusion  ||| S:1764 E:1776 ||| JJ
phase  ||| S:1776 E:1782 ||| NN
( ||| S:1782 E:1783 ||| -LRB-
r2  ||| S:1783 E:1786 ||| CD
=  ||| S:1786 E:1788 ||| SYM
0.42 ||| S:1788 E:1792 ||| CD
;  ||| S:1792 E:1794 ||| :
P  ||| S:1794 E:1796 ||| NNP
< ||| S:1796 E:1798 ||| SYM
0.0001 ||| S:1798 E:1804 ||| NNP
) ||| S:1804 E:1805 ||| -RRB-
.  ||| S:1805 E:1807 ||| .
Changes  ||| S:1807 E:1815 ||| NNS
in  ||| S:1815 E:1818 ||| IN
NIR  ||| S:1818 E:1822 ||| NNP
VO2  ||| S:1822 E:1826 ||| NNP
after  ||| S:1826 E:1832 ||| IN
transfusion  ||| S:1832 E:1844 ||| NN
were  ||| S:1844 E:1849 ||| VBD
also  ||| S:1849 E:1854 ||| RB
negatively  ||| S:1854 E:1865 ||| RB
correlated  ||| S:1865 E:1876 ||| VBN
with  ||| S:1876 E:1881 ||| IN
baseline  ||| S:1881 E:1890 ||| JJ
NIR  ||| S:1890 E:1894 ||| NNP
VO2  ||| S:1894 E:1898 ||| NNP
( ||| S:1898 E:1899 ||| -LRB-
r2  ||| S:1899 E:1902 ||| CD
=  ||| S:1902 E:1904 ||| SYM
0.48 ||| S:1904 E:1908 ||| CD
;  ||| S:1908 E:1910 ||| :
P  ||| S:1910 E:1912 ||| NN
=  ||| S:1912 E:1914 ||| SYM
0.0015 ||| S:1914 E:1920 ||| CD
) ||| S:1920 E:1921 ||| -RRB-
.  ||| S:1921 E:1923 ||| .
There  ||| S:1923 E:1929 ||| EX
were  ||| S:1929 E:1934 ||| VBD
no  ||| S:1934 E:1937 ||| DT
correlations  ||| S:1937 E:1950 ||| NN
between  ||| S:1950 E:1958 ||| IN
RBC  ||| S:1958 E:1962 ||| NNP
storage  ||| S:1962 E:1970 ||| NN
time  ||| S:1970 E:1975 ||| NN
and  ||| S:1975 E:1979 ||| CC
changes  ||| S:1979 E:1987 ||| NNS
in  ||| S:1987 E:1990 ||| IN
StO2  ||| S:1990 E:1995 ||| CD
slope  ||| S:1995 E:2001 ||| NN
or  ||| S:2001 E:2004 ||| CC
NIR  ||| S:2004 E:2008 ||| NNP
VO2 ||| S:2008 E:2011 ||| NNP
.  ||| S:2011 E:2013 ||| .
Muscle  ||| S:2013 E:2020 ||| NN
tissue  ||| S:2020 E:2027 ||| NN
oxygenation ||| S:2027 E:2038 ||| NN
,  ||| S:2038 E:2040 ||| ,
oxygen  ||| S:2040 E:2047 ||| JJ
consumption  ||| S:2047 E:2059 ||| NN
and  ||| S:2059 E:2063 ||| CC
microvascular  ||| S:2063 E:2077 ||| JJ
reactivity  ||| S:2077 E:2088 ||| NNS
are  ||| S:2088 E:2092 ||| VBP
globally  ||| S:2092 E:2101 ||| RB
unaltered  ||| S:2101 E:2111 ||| VBN
by  ||| S:2111 E:2114 ||| IN
RBC  ||| S:2114 E:2118 ||| NNP
transfusion  ||| S:2118 E:2130 ||| NN
in  ||| S:2130 E:2133 ||| IN
critically  ||| S:2133 E:2144 ||| RB
ill  ||| S:2144 E:2148 ||| JJ
patients ||| S:2148 E:2156 ||| NNS
.  ||| S:2156 E:2158 ||| .
However ||| S:2158 E:2165 ||| RB
,  ||| S:2165 E:2167 ||| ,
muscle  ||| S:2167 E:2174 ||| NN
oxygen  ||| S:2174 E:2181 ||| NN
consumption  ||| S:2181 E:2193 ||| NN
and  ||| S:2193 E:2197 ||| CC
microvascular  ||| S:2197 E:2211 ||| JJ
reactivity  ||| S:2211 E:2222 ||| NN
can  ||| S:2222 E:2226 ||| MD
improve  ||| S:2226 E:2234 ||| VB
following  ||| S:2234 E:2244 ||| VBG
transfusion  ||| S:2244 E:2256 ||| NN
in  ||| S:2256 E:2259 ||| IN
patients  ||| S:2259 E:2268 ||| NNS
with  ||| S:2268 E:2273 ||| IN
alterations  ||| S:2273 E:2285 ||| NN
of  ||| S:2285 E:2288 ||| IN
these  ||| S:2288 E:2294 ||| DT
variables  ||| S:2294 E:2304 ||| NNS
at  ||| S:2304 E:2307 ||| IN
baseline ||| S:2307 E:2315 ||| NN
.  ||| S:2315 E:2317 ||| .
